Empowered Funds LLC grew its stake in shares of Select Medical Holdings Corporation (NYSE:SEM – Free Report) by 96.0% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 613,801 shares of the health services provider’s stock after buying an additional 300,631 shares during the quarter. Empowered Funds LLC owned 0.48% of Select Medical worth $10,250,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Caitong International Asset Management Co. Ltd raised its position in Select Medical by 61.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 2,703 shares of the health services provider’s stock valued at $45,000 after purchasing an additional 1,030 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S bought a new position in shares of Select Medical during the 1st quarter valued at about $60,000. Advisors Asset Management Inc. lifted its position in Select Medical by 168.2% in the 1st quarter. Advisors Asset Management Inc. now owns 6,301 shares of the health services provider’s stock worth $105,000 after buying an additional 3,952 shares during the last quarter. GAMMA Investing LLC boosted its stake in Select Medical by 217.4% in the first quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider’s stock worth $109,000 after buying an additional 4,453 shares in the last quarter. Finally, Lazard Asset Management LLC grew its position in Select Medical by 47.8% during the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider’s stock valued at $130,000 after acquiring an additional 2,255 shares during the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.
Select Medical Stock Down 2.4%
Shares of NYSE:SEM opened at $12.93 on Wednesday. Select Medical Holdings Corporation has a 1 year low of $11.65 and a 1 year high of $40.98. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.15 and a quick ratio of 1.15. The stock’s 50-day moving average is $13.57 and its 200 day moving average is $15.23. The company has a market cap of $1.60 billion, a PE ratio of 12.20, a P/E/G ratio of 0.54 and a beta of 1.25.
Select Medical Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Wednesday, August 13th were given a dividend of $0.0625 per share. The ex-dividend date was Wednesday, August 13th. This represents a $0.25 annualized dividend and a dividend yield of 1.9%. Select Medical’s payout ratio is currently 23.58%.
Analysts Set New Price Targets
Separately, UBS Group reaffirmed a “neutral” rating and issued a $14.00 price objective (down previously from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $20.25.
Get Our Latest Stock Analysis on Select Medical
Select Medical Profile
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Read More
- Five stocks we like better than Select Medical
- How to Profit From Value Investing
- Is Qualcomm Tesla’s Next Rival in Autonomous Driving?
- About the Markup Calculator
- 3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
- Why Are These Companies Considered Blue Chips?
- The Quiet Before the Catalyst: Vertical Aerospace’s Next Move
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.